Close

Biotech Acquisition (BIOT) Submits S-4 Prospectus Supplement for Proposed Merger with Blade Therapeutics

May 24, 2022 9:14 AM EDT Send to a Friend
Biotech Acquisition Company (NASDAQ: BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login